A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma

PURPOSE: The optimal perioperative treatment for resectable esophageal squamous cell carcinoma (ESCC) remains controversial. We evaluated the efficacy and safety of leucovorin and 5-fluorouracil (LV5FU2) and LV5FU2 plus oxaliplatin (FOLFOX) combination chemotherapies administered adjuvantly for cura...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung Hee, Shim, Young Mog, Park, Se Hoon, Kim, Hong Kwan, Choi, Young Soo, Ahn, Myung-Ju, Park, Keunchil, Zo, Jae Ill, Sun, Jong-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512359/
https://www.ncbi.nlm.nih.gov/pubmed/27857024
http://dx.doi.org/10.4143/crt.2016.417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512359/
https://www.ncbi.nlm.nih.gov/pubmed/27857024
http://dx.doi.org/10.4143/crt.2016.417

Ejemplares similares